• 2313 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2003Residency, Royal College of Physicians, Ireland
2009Fellowship, University of Texas Health Science Center, San Antonio
2009Fellowship, Royal College of Physicians, Ireland

Education/Academic qualification

PhD, National University of Ireland

… → 2009

MBBChBAO, National University of Ireland

… → 2000

Fingerprint Dive into the research topics where Devalingam Mahalingam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
TNF-Related Apoptosis-Inducing Ligand Receptors Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2017 2022

Research Output 2008 2019

Heightened JNK activation and reduced XIAP levels promote TRAIL and sunitinib-mediated apoptosis in colon cancer models

Mahalingam, D., Carew, J. S., Espitia, C. M., Cool, R. H., Giles, F. J., De Jong, S. & Nawrocki, S. T., Jul 1 2019, In : Cancers. 11, 7, 895.

Research output: Contribution to journalArticle

Open Access
X-Linked Inhibitor of Apoptosis Protein
Colonic Neoplasms

Phase 1 open-label, multicenter study of first-in-class RORγ agonist LYC-55716 (Cintirorgon): Safety, tolerability, and preliminary evidence of antitumor activity

Mahalingam, D., Wang, J. S., Hamilton, E. P., Sarantopoulos, J., Nemunaitis, J., Weems, G., Carter, L., Hu, X., Schreeder, M. & Wilkins, H. J., Jun 15 2019, In : Clinical Cancer Research. 25, 12, p. 3508-3516 9 p.

Research output: Contribution to journalArticle

Open Access
Multicenter Studies
Hepatocellular Carcinoma
Research Ethics Committees
ROC Curve
10 Citations (Scopus)

A phase ii study of pelareorep (REOLYSIN®) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma

Mahalingam, D., Goel, S., Aparo, S., Arora, S. P., Noronha, N., Tran, H., Chakrabarty, R., Selvaggi, G., Gutierrez, A., Coffey, M., Nawrocki, S. T., Nuovo, G. & Mita, M. M., Jun 1 2018, In : Cancers. 10, 6, 160.

Research output: Contribution to journalArticle

Oncolytic Virotherapy
Mammalian orthoreovirus 3
Survival Rate

Case report of prostate ductal adenocarcinoma presenting with hematuria

Pawlowski, J., Swanson, G. P., Mahalingam, D. & Ha, C. S., Jul 1 2018, In : Urology Case Reports. 19, p. 63-64 2 p.

Research output: Contribution to journalArticle